Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""TNPO2"" wg kryterium: Temat


Wyświetlanie 1-5 z 5
Tytuł:
TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis
Autorzy:
Libao Gong
Ti Wen
Zhi Li
Yizhe Wang
Jin Wang
Xiaofang Che
Yunpeng Liu
Xiujuan Qu
Pokaż więcej
Temat:
DYNC1I1
gastric cancer
P300
proliferation
SP1
TNPO2
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
Cancer Medicine, Vol 8, Iss 17, Pp 7299-7312 (2019)
Opis pliku:
electronic resource
Relacje:
https://doaj.org/toc/2045-7634
Dostęp URL:
https://doaj.org/article/7c561094e364433f915d64c98db061f4  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
TNPO2 operates downstream of DYNC1I1 and promotes gastric cancer cell proliferation and inhibits apoptosis.
Autorzy:
Gong L; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Wen T; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Li Z; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Wang Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Wang J; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Che X; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Liu Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Qu X; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Dec; Vol. 8 (17), pp. 7299-7312. Date of Electronic Publication: 2019 Oct 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Nucleus/*metabolism
Cytoplasmic Dyneins/*metabolism
Stomach Neoplasms/*pathology
beta Karyopherins/*metabolism
Acetylation ; Active Transport, Cell Nucleus ; Apoptosis/genetics ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cyclin-Dependent Kinase Inhibitor p21/metabolism ; E1A-Associated p300 Protein ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Histones/metabolism ; Humans ; Promoter Regions, Genetic/genetics ; Sp1 Transcription Factor/metabolism ; Up-Regulation ; beta Karyopherins/genetics
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies